BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Elekta and Netherlands Cancer Institute (NCI) -Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research

  June 8, 2012

   · 

  3 min read
• UCB, Inc. Release: Post Hoc Analysis Indicated That Timing and Magnitude of Initial Response to Certolizumab Pegol Predicted Likelihood of Low Disease Activity at Week 28 in Patients With Active Moderate to Severe Rheumatoid Arthritis

  June 8, 2012

   · 

  21 min read
• Drug Development

  Data From Follow-Up Study of Vertex Pharmaceuticals Incorporated’ KALYDECO™ (ivacaftor) Showed Durable Improvements in Lung Function and Other Measures of Disease in People With Cystic Fibrosis Who Have a Specific Genetic Mutation (G551D)

  June 8, 2012

   · 

  11 min read
• Drug Development

  Versartis, Inc. Announces Publication of Preclinical Data for Once Monthly Human Growth Hormone Treatment in Journal of Pharmaceutical Sciences

  June 8, 2012

   · 

  3 min read
• Biostem U.S. Corporation Engages Acropolis Agency to Assist in Implementing Its International Marketing Plan

  June 8, 2012

   · 

  1 min read
• Genetown

  Coronado Biosciences Receives Notice of Allowance for First U.S. Patent Covering CNDO-109

  June 8, 2012

   · 

  1 min read
• Biotech Bay

  Company Profile for SentreHEART, Inc.

  June 8, 2012

   · 

  1 min read
• BioMidwest

  W. L. Gore & Associates, Inc. Joins SVS in Honoring Winners of the 2012 SVS Women’s Leadership Training Grant for Vascular Surgeons

  June 8, 2012

   · 

  1 min read
• GlobalData Release: Osteoarthritis Pain Medications Struggle to Impress in Advanced Cases

  June 8, 2012

   · 

  3 min read
• Ontario Institute for Cancer Research Funds Fluorinov Pharma Inc. to Further Develop Its Novel Drug for the Treatment of Blood Cancers

  June 8, 2012

   · 

  3 min read